Matches in Wikidata for { <http://www.wikidata.org/entity/Q79112301> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q79112301 description "clinical trial" @default.
- Q79112301 description "ensayu clínicu" @default.
- Q79112301 description "klinisch onderzoek" @default.
- Q79112301 description "клінічне випробування" @default.
- Q79112301 description "կլինիկական փորձարկում" @default.
- Q79112301 name "Study Comparing the Efficacy and Safety of EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer" @default.
- Q79112301 name "Study Comparing the Efficacy and Safety of EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer" @default.
- Q79112301 type Item @default.
- Q79112301 label "Study Comparing the Efficacy and Safety of EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer" @default.
- Q79112301 label "Study Comparing the Efficacy and Safety of EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer" @default.
- Q79112301 prefLabel "Study Comparing the Efficacy and Safety of EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer" @default.
- Q79112301 prefLabel "Study Comparing the Efficacy and Safety of EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer" @default.
- Q79112301 P1132 Q79112301-F6D80AC1-9056-42C1-9795-1D02630C4FC3 @default.
- Q79112301 P1476 Q79112301-5E87E016-9B20-41EF-92D2-58D493CDD04C @default.
- Q79112301 P1813 Q79112301-6FE9E200-93D7-43D2-AF2D-BC209B893A44 @default.
- Q79112301 P2899 Q79112301-0E25C7D1-B5CD-43FE-B405-6BE50718F687 @default.
- Q79112301 P3098 Q79112301-CC79581E-7D8B-4C78-AD89-15C28E52422F @default.
- Q79112301 P31 Q79112301-7F1B44C1-9213-465C-AD73-245198DB20D7 @default.
- Q79112301 P4135 Q79112301-5AABA7EE-3887-4253-9CE5-CF7C6B96C95D @default.
- Q79112301 P4844 Q79112301-413D178C-A2DE-4578-96B0-2E8D18314E60 @default.
- Q79112301 P4844 Q79112301-938C6441-F926-4066-BE10-AC5CFBEF8B64 @default.
- Q79112301 P4844 Q79112301-D0B7BAF1-EC8E-446D-8AEB-47B7DE2CFF4F @default.
- Q79112301 P580 Q79112301-DF0002F3-C0C9-44D6-A24A-40A4B080330A @default.
- Q79112301 P582 Q79112301-8D0A8428-D1C5-4D58-AD91-6BBEDE283478 @default.
- Q79112301 P6099 Q79112301-7F0FEE82-587A-4A2A-9571-EE06ED5CC86F @default.
- Q79112301 P8363 Q79112301-F5D299CA-4224-4E76-86D7-94A408DF7A1C @default.
- Q79112301 P859 Q79112301-B1D2B344-7154-4930-9EF0-70068D8E0FF9 @default.
- Q79112301 P1132 "+1560" @default.
- Q79112301 P1476 "Study Comparing the Efficacy and Safety of Epirubicin Combined With Cyclophosphamide Followed by Docetaxel (EC-T) Verses Paclitaxel Combined With Carboplatin (PCb) in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer" @default.
- Q79112301 P1813 "PANSY" @default.
- Q79112301 P2899 "+18" @default.
- Q79112301 P3098 "NCT04193059" @default.
- Q79112301 P31 Q30612 @default.
- Q79112301 P4135 "+70" @default.
- Q79112301 P4844 Q408524 @default.
- Q79112301 P4844 Q415588 @default.
- Q79112301 P4844 Q423762 @default.
- Q79112301 P580 "2018-08-01T00:00:00Z" @default.
- Q79112301 P582 "2021-07-01T00:00:00Z" @default.
- Q79112301 P6099 Q42824827 @default.
- Q79112301 P8363 Q78089383 @default.
- Q79112301 P859 Q495015 @default.